CORE--EDUCATION AND TRAINING

核心——教育与培训

基本信息

项目摘要

The Education and Information Transfer Core provides both training in basic science and clinical aspects of Alzheimer's disease, and information transfer within the ADRC, to health professional in the community, to caregivers and to the general public. The overall objective of research training is to increase the number of scientists focusing their research on Alzheimer's disease. These scientists are trained mainly through traditional pre- and post-doctoral training programs in which the training participates directly in a research project. In addition, this Core provides two on-going seminars on AD research, and support to a number of ongoing research activities involving dementia and aging research at UCSD: the Graduate Program in Neurosciences, the Graduate Program in Biomedical Sciences, the Gero-Psychiatry Unit at the VA Medical Center, and the Institute for Research on Aging lecture series. This support includes speakers and seminars, information, coordinating schedules for conferences and courses, and access for students, post-doctoral fellows, and active scientists to interface with or directly participate in the ADRC's research activities. We train between 60 and 70 researchers per five year grant cycle. The overall objectives in information transfer are to improve the skills of health care professionals in dealing with Alzheimer's disease,. to educate the general public about Alzheimer's disease, and to provide information about the ADRC activities and support to caregivers. Activities include: 1. A two-week Mini-residency program for practicing health care professionals. Participants learn from one-on-one interactions with ADRC faculty and actual AD patients. 2. An accredited annual CME conference, training both professionals and caregivers. Attendance has increased, with more than 300 professionals at our most recent conference. 3. Health professional, caregiver and public education by ADRC staff though numerous lectures, conferences and seminars and in-service training about research advances, diagnosis, and management of AD (reaching an audience of over 10,000, not including television and radio). 4. In addition to continuing these activities, a special attempt will be made to educate Hispanic physicians and the local Hispanic community about AD, with the goals of providing better diagnosis and care of current D victims, as well as increasing minority participation in AD research.
教育和信息转移核心既可以为阿尔茨海默氏病的基础科学和临床方面的培训,以及在ADRC内部的信息转移,向社区中的卫生专业人员,照顾者和公众。研究培训的总体目标是增加将研究重点放在阿尔茨海默氏病上的科学家的数量。这些科学家主要通过传统的博士后和博士后培训计划进行培训,其中培训直接参与了研究项目。此外,该核心提供了两个正在进行的有关AD研究的研讨会,并为UCSD的许多正在进行的研究活动提供了支持:神经科学研究生课程,生物医学研究生课程,生物医学研究生课程,VA医疗中心的Gero-Psychiatry部门,以及有关Aging aging Lecter nectle lecte cepret of Aging Medical Cente。该支持包括演讲者和研讨会,信息,协调会议和课程的协调时间表,以及学生的访问,博士后研究员以及活跃的科学家,可以与ADRC的研究活动进行接触或直接参与。我们每五年赠款周期训练60至70名研究人员。信息转移的总体目标是提高医疗保健专业人员在处理阿尔茨海默氏病方面的技能。向公众教育有关阿尔茨海默氏病的知识,并提供有关ADRC活动和支持的信息。活动包括:1个为期两周的小型居住计划,用于执业医疗保健专业人员。参与者从与ADRC教师和实际AD患者的一对一互动中学习。 2。认可的年度CME会议,培训专业人士和看护人。出勤率有所增加,我们最近的会议上有300多名专业人员。 3. ADRC员工的卫生专业人员,护理人员和公共教育,虽然许多讲座,会议和研讨会以及有关AD的研究进展,诊断和管理的服务培训(吸引了10,000多人的受众,不包括电视和广播)。 4。除了继续这些活动外,还将进行特殊尝试,以教育西班牙裔医师和当地西班牙裔社区有关AD的知识,其目标是为当前的D受害者提供更好的诊断和照顾,并增加少数群体参与AD研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOE WESLEY RAMSDELL其他文献

JOE WESLEY RAMSDELL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOE WESLEY RAMSDELL', 18)}}的其他基金

Smoking in Asthmatics Pilot Study
吸烟与哮喘的试点研究
  • 批准号:
    8302686
  • 财政年份:
    2012
  • 资助金额:
    $ 0.92万
  • 项目类别:
Smoking in Asthmatics Pilot Study
吸烟与哮喘的试点研究
  • 批准号:
    8446324
  • 财政年份:
    2012
  • 资助金额:
    $ 0.92万
  • 项目类别:
COPD EPIDEMIOLOGY WHOLE GENOME ANALYSIS PROJECT
慢性阻塞性肺病流行病学全基因组分析项目
  • 批准号:
    8166873
  • 财政年份:
    2009
  • 资助金额:
    $ 0.92万
  • 项目类别:
CORE--EDUCATION AND TRAINING
核心——教育与培训
  • 批准号:
    6398170
  • 财政年份:
    2000
  • 资助金额:
    $ 0.92万
  • 项目类别:
CLINICAL CENTERS FOR FEASIBILITY STUDIES ON RETINOID TRE
维甲酸 TRE 可行性研究临床中心
  • 批准号:
    6356164
  • 财政年份:
    1999
  • 资助金额:
    $ 0.92万
  • 项目类别:
CORE--EDUCATION AND TRAINING
核心——教育与培训
  • 批准号:
    6396618
  • 财政年份:
    1999
  • 资助金额:
    $ 0.92万
  • 项目类别:
CLINICAL CENTERS FOR FEASIBILITY STUDIES ON RETINOID TRE
维甲酸 TRE 可行性研究临床中心
  • 批准号:
    6286796
  • 财政年份:
    1999
  • 资助金额:
    $ 0.92万
  • 项目类别:
CORE--EDUCATION AND TRAINING
核心——教育与培训
  • 批准号:
    6098016
  • 财政年份:
    1999
  • 资助金额:
    $ 0.92万
  • 项目类别:
CLINICAL CENTERS FOR FEASIBILITY STUDIES ON RETINOID TRE
维甲酸 TRE 可行性研究临床中心
  • 批准号:
    6191636
  • 财政年份:
    1999
  • 资助金额:
    $ 0.92万
  • 项目类别:
CLINICAL TRIAL OF MEDICAL THERAPY IN BENIGN PROSTATIC HYPERPLASIA
良性前列腺增生药物治疗的临床试验
  • 批准号:
    6117943
  • 财政年份:
    1998
  • 资助金额:
    $ 0.92万
  • 项目类别:

相似海外基金

Measuring the Impact of the Value Flower and Unobserved Heterogeneity on the Cost Effectiveness and Use of Novel Treatments for Alzheimer's Disease and Related Dementias
衡量价值花和未观察到的异质性对阿尔茨海默病和相关痴呆症新疗法的成本效益和使用的影响
  • 批准号:
    10658457
  • 财政年份:
    2023
  • 资助金额:
    $ 0.92万
  • 项目类别:
Annual wellness visit policy: Impact on disparities in early dementia diagnosis and quality of healthcare for Medicare beneficiaries with Alzheimer's Disease and Its Related Dementias
年度健康就诊政策:对患有阿尔茨海默病及其相关痴呆症的医疗保险受益人的早期痴呆诊断和医疗质量差异的影响
  • 批准号:
    10729272
  • 财政年份:
    2023
  • 资助金额:
    $ 0.92万
  • 项目类别:
Shape-based personalized AT(N) imaging markers of Alzheimer's disease
基于形状的个性化阿尔茨海默病 AT(N) 成像标记
  • 批准号:
    10667903
  • 财政年份:
    2023
  • 资助金额:
    $ 0.92万
  • 项目类别:
Helping Behaviors and Cognitive Functioning in Later Life: Linkages with Genetic Risks for Alzheimer's Disease and Disadvantaged Neighborhood Socioeconomic Status
帮助晚年生活的行为和认知功能:与阿尔茨海默病遗传风险和弱势社区社会经济状况的联系
  • 批准号:
    10739889
  • 财政年份:
    2023
  • 资助金额:
    $ 0.92万
  • 项目类别:
Alzheimer's Disease and Related Dementias Innovation Incubator (InnovaTor)
阿尔茨海默病及相关痴呆症创新孵化器 (InnovaTor)
  • 批准号:
    10738969
  • 财政年份:
    2023
  • 资助金额:
    $ 0.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了